I've seen this over the past year or two on several biotechs -...

I've seen this over the past year or two on several biotechs - they are all raising on the announcement of good news, not letting it run! I suspect it's a combination of reasons - reward instos and sophs that have supported them, guaranteed cash - bird-in-the-hand and all that (whereas if you let it run who knows for sure), short & sweet CR - no drawn out period waiting to see if tight-arse shareholders will fully support or not (history has shown they haven't, for many). Anybody who was disgruntled about not being offered a spot in the CR has had every opportunity today to buy in for the CR price or less. I hope they made the most of the opportunity, because we won't be staying in the 6c range for long.

We are now fully cashed up with no money distractions through to the end of the Ph2 and beyond. SNT are in a position of strength now for when the full results come in mid-2025! That's why we won't be staying this low for long.